ADAMS ADRIAN
Insider CIK 1248144 · POZN Chief Executive Officer, Director · AUXL CEO and President, Director · ACRX Director · IMPL COB, CEO and President, Director · AKBA Director · ARLZ Chief Executive Officer, Director · AMLN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TLPH TALPHERA, INC. | A Award deriv | 2026-06-22 | 2026-06-24 | 30,700 | — | $0 | 30,700 | SEC↗ |
| TLPH TALPHERA, INC. | A Award | 2026-06-22 | 2026-06-24 | 5,100 | — | $0 | 22,709 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2026-06-17 | 2026-06-22 | 53,600 | — | $0 | 53,600 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2026-06-17 | 2026-06-22 | 35,700 | — | $0 | 236,200 | SEC↗ |
| TLPH TALPHERA, INC. | A Award deriv | 2025-10-23 | 2025-10-24 | 25,600 | — | $0 | 25,600 | SEC↗ |
| TLPH TALPHERA, INC. | A Award | 2025-10-23 | 2025-10-24 | 4,267 | — | $0 | 17,609 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2025-06-10 | 2025-06-11 | 53,600 | — | $0 | 53,600 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2025-06-10 | 2025-06-11 | 35,700 | — | $0 | 200,500 | SEC↗ |
| TLPH TALPHERA, INC. | A Award deriv | 2024-06-24 | 2024-06-24 | 13,044 | — | $0 | 13,044 | SEC↗ |
| TLPH TALPHERA, INC. | A Award | 2024-06-24 | 2024-06-24 | 2,174 | — | $0 | 13,342 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2024-06-06 | 2024-06-10 | 45,000 | — | $0 | 45,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2024-06-06 | 2024-06-10 | 30,000 | — | $0 | 164,800 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2023-10-10 | 2023-12-13 | 3,487 | — | $0 | 3,487 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award | 2023-10-10 | 2023-12-13 | 581 | — | $0 | 11,168 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 45,000 | — | $0 | 45,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2023-06-06 | 2023-06-08 | 30,000 | — | $0 | 134,800 | SEC↗ |
| IMPL IMPEL PHARMACEUTICALS INC | A Award deriv | 2023-02-14 | 2023-02-16 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2022-07-15 | 2022-07-15 | 31,000 | — | $0 | 31,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award | 2022-07-15 | 2022-07-15 | 15,500 | — | $0 | 211,750 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2022-06-08 | 2022-06-09 | 20,100 | — | $0 | 20,100 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2022-06-08 | 2022-06-09 | 13,700 | — | $0 | 104,800 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | A Award deriv | 2022-01-26 | 2022-01-28 | 175,000 | — | $0 | 175,000 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | P Buy | 2021-08-18 | 2021-08-19 | 600 | $15.89 | $9.5K | 20,000 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | P Buy | 2021-08-18 | 2021-08-19 | 2,197 | $14.91 | $32.8K | 19,400 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | P Buy | 2021-08-18 | 2021-08-19 | 17,203 | $13.81 | $237.6K | 17,203 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | A Award deriv | 2021-07-20 | 2021-07-26 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2021-06-17 | 2021-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award | 2021-06-17 | 2021-06-17 | 10,000 | — | $0 | 196,250 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2021-06-02 | 2021-06-03 | 20,100 | — | $0 | 20,100 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2021-06-02 | 2021-06-03 | 13,700 | — | $0 | 91,100 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2020-06-16 | 2020-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award | 2020-06-16 | 2020-06-16 | 7,500 | — | $0 | 186,250 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2020-06-15 | 2020-06-15 | 100,000 | $1.29 | $129.0K | 178,750 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2020-06-15 | 2020-06-15 | 100,000 | $1.29 | $129.0K | 178,750 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2020-06-05 | 2020-06-09 | 20,100 | — | $0 | 20,100 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2020-06-05 | 2020-06-09 | 13,700 | — | $0 | 77,400 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | P Buy | 2019-11-20 | 2019-11-21 | 50,000 | $3.41 | $170.5K | 63,700 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2019-06-25 | 2019-06-25 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award | 2019-06-25 | 2019-06-25 | 3,750 | — | $0 | 78,750 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2019-06-06 | 2019-06-10 | 20,100 | — | $0 | 20,100 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2019-06-06 | 2019-06-10 | 13,700 | — | $0 | 13,700 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2018-12-12 | 2018-12-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2018-06-14 | 2018-06-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2017-06-15 | 2017-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | A Award deriv | 2017-05-11 | 2017-05-12 | 252,316 | — | $0 | 252,316 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | A Award | 2017-05-11 | 2017-05-12 | 218,380 | — | $0 | 3,787,610 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | P Buy | 2017-03-15 | 2017-03-17 | 500,000 | $2.46 | $1.23M | 3,569,230 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2016-06-21 | 2016-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | A Award deriv | 2016-03-17 | 2016-03-18 | 105,251 | — | $0 | 105,251 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | A Award | 2016-03-17 | 2016-03-18 | 124,342 | — | $0 | 3,069,230 | SEC↗ |
| ARLZ Aralez Pharmaceuticals Inc | J Other | 2016-02-05 | 2016-02-09 | 2,944,888 | — | $0 | 2,944,888 | SEC↗ |
| POZN POZEN INC /NC | P Buy | 2015-11-12 | 2015-11-12 | 448,529 | $6.68 | $3.00M | 2,944,888 | SEC↗ |
| POZN POZEN INC /NC | P Buy | 2015-11-11 | 2015-11-12 | 551,471 | $6.45 | $3.56M | 2,496,359 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2015-06-23 | 2015-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| POZN POZEN INC /NC | A Award | 2015-06-03 | 2015-06-05 | 1,944,888 | — | $0 | 1,944,888 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other deriv | 2015-01-29 | 2015-01-30 | 510,000 | $36.53 | $18.63M | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other deriv | 2015-01-29 | 2015-01-30 | 129,000 | $36.53 | $4.71M | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other deriv | 2015-01-29 | 2015-01-30 | 156,500 | $36.53 | $5.72M | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other | 2015-01-29 | 2015-01-30 | 97,644 | — | $0 | 120,134 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other | 2015-01-29 | 2015-01-30 | 120,134 | $36.53 | $4.39M | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | M Exercise deriv | 2014-12-05 | 2014-12-08 | 40,000 | — | $0 | 510,000 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | S Sale | 2014-12-05 | 2014-12-08 | 40,000 | $33.97 | $1.36M | 217,778 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | M Exercise | 2014-12-05 | 2014-12-08 | 40,000 | $17.40 | $696.0K | 257,778 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2014-07-24 | 2014-07-28 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award deriv | 2014-02-18 | 2014-02-20 | 58,000 | — | $0 | 58,000 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award deriv | 2014-02-18 | 2014-02-20 | 156,500 | — | $0 | 156,500 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2014-02-18 | 2014-02-20 | 23,775 | — | $0 | 155,278 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2014-02-18 | 2014-02-20 | 62,500 | — | $0 | 217,778 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2014-02-18 | 2014-03-12 | 62,500 | — | $0 | 217,778 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy deriv | 2013-09-12 | 2013-09-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2013-05-28 | 2013-05-29 | 50,000 | $8.39 | $419.5K | 75,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2013-05-24 | 2013-05-29 | 25,000 | $7.78 | $194.5K | 25,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2013-02-11 | 2013-02-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2013-02-08 | 2014-03-12 | 51,600 | — | $0 | 130,162 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award deriv | 2013-02-08 | 2013-02-11 | 129,000 | — | $0 | 129,000 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2013-02-08 | 2013-02-11 | 51,600 | — | $0 | 130,162 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2013-02-07 | 2013-02-11 | 21,480 | — | $0 | 78,562 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | P Buy | 2012-12-14 | 2012-12-17 | 56,000 | — | $0 | 56,579 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | H Expire deriv | 2012-08-08 | 2012-08-10 | 12,000 | — | $0 | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | H Expire deriv | 2012-08-08 | 2012-08-10 | 20,000 | — | $0 | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 20,000 | $31.00 | $620.0K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 20,000 | $31.00 | $620.0K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 20,000 | $31.00 | $620.0K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other deriv | 2012-08-08 | 2012-08-10 | 20,000 | $31.00 | $620.0K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 10,800 | $31.00 | $334.8K | 10,200 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | J Other | 2012-08-08 | 2012-08-10 | 10,200 | $31.00 | $316.2K | 0 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award deriv | 2012-05-15 | 2012-05-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AMLN AMYLIN PHARMACEUTICALS INC | A Award | 2012-05-15 | 2012-05-17 | 3,000 | — | $0 | 21,000 | SEC↗ |